Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $12 | $6 | $8 | $6 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $12 | $6 | $8 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -16,626.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -13,162.4% |
| EPS Diluted | -3.01 | -3.16 | -2.75 | -2.47 |
| % Growth | 4.7% | -14.9% | -11.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |